166 
DR. FREDRICKSON: We have that statement, then. And you refer now, in 
that statement, to the document signed by the Boston DNA Recombinant Group? 
DR. GOLDSTEIN: This is the one dated 8 February, 1976 that I wrote 
Sunday night. 
SPEAKER: It was handed out yesterday. 
DR. FREDRICKSON: It was handed out. We have it. 
MR. HUTT: It is on the stationery of the Department of Microbiology of 
the Harvard Medical School. 
DPv. FREDRICKSON: Thank you. If we have time. Dr. Goldstein, we will 
ask you to read that; otherwise we will make sure that it is given the same 
careful consideration that it would have received had you spoken it. Thank 
you. 
DR. WIESENFELD: I would like to respond to what Dr. Melnick said. Can 
I make just one short comment? 
DR. FREDRICKSON: Yes, one short comment. 
DR. WIESENFELD: I would just like to say that a virus — 
DR. FREDRICKSON: Would you identify yourself? 
DR. WIESENFELD: I am Dr. Wiesenfeld. 
DR. FREDRICKSON: And would you stand up so that you can be caught in 
the mikes? 
DR. WIESENFELD: I would just like to mention that a virus indistin- 
guishable from SV40 has been isolated from a progressive disease of the 
central nervous system, progressive multifocal leukoencephalopathy . I think 
references to that are in the guidelines in regard to SV40. So we don't 
really have total evidence that SV40 is benign over a long period of time 
for humans. 
DR. FREDRICKSON: Thank you. 
Dr. Rowe? You have asked to speak as a member of the committee. 
Dr. Rowe, I shall be tough with you on time as well. Can you finish within 
ten minutes? 
DR. ROWE: Oh, certainly. 
DR. FREDRICKSON: Very good. 
[ 307 ] 
